
Tetra Technologies (TTI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
TETRA Technologies, Inc. is a diversified oil and gas services company. The company is headquartered in The Woodlands, Texas.
| Revenue (TTM) | $630.04M |
| Gross Profit (TTM) | $192.04M |
| EBITDA | $90.24M |
| Operating Margin | 8.20% |
| Return on Equity | 3.04% |
| Return on Assets | 5.20% |
| Revenue/Share (TTM) | $4.71 |
| Book Value | $2.12 |
| Price-to-Book | 4.84 |
| Price-to-Sales (TTM) | 2.19 |
| EV/Revenue | 2.505 |
| EV/EBITDA | 18.36 |
| Quarterly Earnings Growth (YoY) | 100.00% |
| Quarterly Revenue Growth (YoY) | -0.60% |
| Shares Outstanding | $147.82M |
| Float | $127.64M |
| % Insiders | 5.45% |
| % Institutions | 80.89% |
Volatility is currently expanding

Tetra Technologies (TTI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Using Neptune Chemistry to Achieve Required Density With Lower Zinc Content; Awarded Three-Well 20k psi Deepwater Project in the Gulf of America With Estimated Start in 2026 SPRING, Texas, June 29, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE: TTI) today announced the introduction of TETRA Neptune Z-Lite, a high-density completion fluid designed for deepwater and high-pressure well applications. The fluid system uses our patented Neptune fluid chemistry and expands the Company's completion fluids portfolio by offering up to 60% lower zinc-ion concentration than conventional zinc-based fluids while maintaining required density performance.

TETRA Technologies, Inc. (TTI) Presents at J.P. Morgan Natural Resources Conference 2026 Transcript

San Diego, California--(Newsfile Corp. - June 17, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation cysteamine-based therapies for rare diseases, including cystinosis and primary mitochondrial diseases, today announced the appointment of Gilad Aharon, PhD, to its Board of Directors. Dr. Aharon is a Co-Founder and Portfolio Manager at Rosalind Advisors, Inc., a Toronto-based life sciences institutional investor.

SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the pricing of an underwritten public offering of 10,810,811 shares of its common stock, par value $0.01 per share ("Common Stock"), at a price to the public of $9.25 per share, pursuant to an effective shelf registration statement on Form S-3 (the "Registration Statement") filed with the U.S. Securities and Exchange Commission (the "SEC"). The Company intends to use the net proceeds it receives from the offering for general corporate purposes, including funding a portion of the construction costs of its Arkansas bromine project.

SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the commencement of an underwritten public offering of $100 million of shares of its common stock, par value $0.01 per share ("Common Stock"), pursuant to an effective shelf registration statement on Form S-3 (the "Registration Statement") filed with the U.S. Securities and Exchange Commission (the "SEC"). The Company intends to use the net proceeds it receives from the offering for general corporate purposes, including funding a portion of the construction costs of its Arkansas bromine project.

TETRA Technologies reported decade-high Q1 2026 revenue and EBITDA, with EPS coming 100% above estimates despite flat year-over-year growth. The company is constructing an Arkansas bromine facility for zinc bromide electrolyte battery supply. This is the project that contributes to the growth of the company in the near future. At 14x EV/EBITDA, TTI trades at the same multiple as Generac, although TTI holds bromine supply chain exposure and dominant deepwater completion fluid market share.

SPRING, Texas, April 29, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced financial results for the three months ended March 31, 2026. First-Quarter 2026 Financial Highlights Revenues of $156.3 million Income from continuing operations of $8.3 million, inclusive of $0.5 million of unusual charges Adjusted EBITDA of $25.6 million Income per share from continuing operations of $0.06 Brady Murphy, TETRA's President and Chief Executive Officer, stated, "We are pleased to start 2026 with one of the strongest first quarter performances in the company's past ten years.

Tetra Technologies (TTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SPRING, Texas, April 7, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE:TTI) will release First Quarter 2026 results after the market closes on April 29, 2026. Brady Murphy, President and CEO, and Matt Sanderson, CFO, will host a conference call to discuss the results and outlook on April 30, 2026, at 10:30am ET.